TRCT
SMTI icon

Tower Research Capital (TRC)’s Sanara MedTech SMTI Stock Holding History

Tower Research Capital (TRC)’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.5K Buy
901
+282
+46% +$5.8K ﹤0.01% 3664
2025
Q4 		$14.5K Buy
619
+252
+69% +$6.51K ﹤0.01% 3348
2025
Q3 		$11.6K Sell
367
-562
-60% -$17K ﹤0.01% 3865
2025
Q2 		$26.4K Buy
929
+551
+146% +$16.5K ﹤0.01% 3513
2025
Q1 		$11.7K Sell
378
-248
-40% -$8.42K ﹤0.01% 3516
2024
Q4 		$20.8K Buy
626
+302
+93% +$10.2K ﹤0.01% 3155
2024
Q3 		$9.8K Sell
324
-1,020
-76% -$31.8K ﹤0.01% 3831
2024
Q2 		$37.9K Buy
1,344
+1,107
+467% +$34.8K ﹤0.01% 3307
2024
Q1 		$8.77K Sell
237
-27
-10% -$1.01K ﹤0.01% 3967
2023
Q4 		$10.8K Sell
264
-533
-67% -$17.1K ﹤0.01% 4195
2023
Q3 		$24.8K Buy
797
+625
+363% +$24.2K ﹤0.01% 3180
2023
Q2 		$6.9K Sell
172
-297
-63% -$12.2K ﹤0.01% 4648
2023
Q1 		$19K Sell
469
-38
-7% -$1.6K ﹤0.01% 3508
2022
Q4 		$23K Buy
507
+153
+43% +$5.27K ﹤0.01% 3006
2022
Q3 		$11K Sell
354
-798
-69% -$22.3K ﹤0.01% 4463
2022
Q2 		$24K Buy
1,152
+842
+272% +$19.7K ﹤0.01% 3616
2022
Q1 		$9K Buy
310
+260
+520% +$6.59K ﹤0.01% 4489
2021
Q4 		$1K Sell
50
-96
-66% -$3.02K ﹤0.01% 5885
2021
Q3 		$5K Buy
+146
New +$5.24K ﹤0.01% 4886
2021
Q2 		– Sell
-393
Closed -$12K – 5812
2021
Q1 		$12K Buy
393
+83
+27% +$2.88K ﹤0.01% 4276
2020
Q4 		$15K Buy
+310
New +$12.2K ﹤0.01% 4060

Other funds holding SMTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Tower Research Capital (TRC)'s SMTI Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Sanara MedTech (SMTI) stake by 46% in Q1 2026, buying an estimated $5.8K and bringing the position to 901 shares worth $15.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3664.

Tower Research Capital (TRC) first reported a position in SMTI in Q4 2020 and has held it in 21 quarters since. The position peaked at $37.9K in Q2 2024. 65 funds tracked by Wall St. Rank hold SMTI as of Q1 2026.

  • Tower Research Capital (TRC) held 901 shares of Sanara MedTech worth $15.5K as of Q1 2026.
  • Tower Research Capital (TRC) bought 282 Sanara MedTech shares in Q1 2026, an estimated $5.8K.
  • Sanara MedTech made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3664 holding.
  • Tower Research Capital (TRC) first reported a position in Sanara MedTech in Q4 2020 and has held it in 21 quarters since.
  • Tower Research Capital (TRC)'s Sanara MedTech position peaked at $37.9K in Q2 2024.
  • 65 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.